Skip to main content
SAWC Spring 2026 Posters Main banner
Left Banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Rate ePoster

(WHS-P103) A Phase I/IIA Open Label Clinical Trial Evaluating the Safety and Preliminary Efficacy of ELU42, a Small Molecule Wnt-Signaling Modulator, in the Treatment of Diabetic Foot Ulcers

Friday, April 10, 2026
7:30 PM - 8:30 PM ET
Daniel Holsworth1, John Delgado1, Michael Stone1, Vickie Driver1, Sarika Saraswati1
1. Eluciderm Inc, San Diego , CA, United States.